Up-regulation of insulin-like growth factor binding protein-5 is independent of muscle cell differentiation, sensitive to rapamycin, but insensitive to wortmannin and LY294002

Endocrinology

Volumn 139, Issue 4, 1998, Pages 1487-1493

  Rousse, Sophie ^a   Montarras, Didier ^b   Pinset, Christian ^b   Dubois, Catherine ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; PROTEIN KINASE; RAPAMYCIN; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN RECEPTOR; TACROLIMUS; WORTMANNIN;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CELL PROLIFERATION; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HORMONAL REGULATION; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; SKELETAL MUSCLE;

EID: 0031765116     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.4.5916     Document Type: Article

References (57)

1. Ewton DZ, Florini JR 1981 Effects of the somatomedins and insulin on myoblast differentiation in vitro. Dev Biol 86:31-39
2. Levinovitz A, Jennische E, Oldfors A, Edwall D, Norstedt G 1992 Activation of insulin-like growth factor II expression during skeletal muscle regeneration in rat: correlation with myotube formation. Mol Endocrinol 6:1227-1234
3. Florini JR, Ewton DZ, Coolican SA 1996 Growth hormone and insulin-like growth factor system in myogenesis. Endocr Revi 17:481-517
4. Florini JR, Magri KA, Ewton DZ, James PL, Grindstaff K, Rotwein PS 1991 "Spontaneous" differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. J Biol Chem 266:15917-15923
5. Ewton DZ, Roof SL, Magri KA, McWade FJ, Florini JR 1994 IGF-II is more active than IGF-I in stimulating L6A1 myogenesis: greater mitogenic actions of IGF-I delay differentiation. J Cell Physiol 16:277-284
6. Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34
7. Schuller AGP, Zwarthoff EC, Drop SLS 1993 Gene expression of the six insulin-like growth factor binding proteins in the mouse conceptus during mid- and late gestation. Endocrinology 132:2544-2550
8. Rechler MM 1993 Insulin-like growth factor binding proteins. Vitam Horm 47:1-114
9. Rosenthal SM, Brunetti A, Brown EJ, Mamula PW, Goldfine ID 1991 Regulation of insulin-like growth factor (IGF) I receptor expression during muscle cell differentiation. J Clin Invest 87:1212-1219
10. Ernst CW, McCusker RH, White ME 1992 Gene expression and secretion of insulin-like growth factor-binding proteins during myoblast differentiation. Endocrinology 130:607-615
11. Ewton DZ, Florini JR 1995 IGF binding proteins-4, -5 and -6 may play specialized roles during L6 myoblast proliferation and differentiation. J Endocrinol 144:539-553
12. McCusker RH, Camacho-Hübner C, Clemmons DR 1989 Identification of the types of insulin-like growth factor-binding proteins that are secreted by muscle cells in vitro. J Biol Chem 264:7795-7800
13. Silverman LA, Cheng ZQ, Hsiao D, Rosenthal SM 1995 Skeletal muscle cell-derived insulin-like growth factor (IGF) binding proteins inhibit IGF-I-induced myogenesis in rat L6E9 cells. Endocrinology 136:720-726
14. James PL, Jones SB, Busby Jr WH, Clemmons DR, Rotwein P 1993 A highly conserved insulin-like growth factor-binding protein (IGF-BP-5) is expressed during myoblast differentiation. J Biol Chem 268:22305-22312
15. Green BN, Jones SB, Streck RD, Wood TL, Rotwein P, Pintar JE 1994 Distinct expression patterns of insulin-like growth factor binding proteins 2 and 5 during fetal and postnatal development. Endocrinology 134:954-962
16. Pinset C, Montarras D, Chenevert J, Minty A, Barton P, Laurent C, Gros F 1988 Control of myogenesis in mouse myogenic C2 cell line by medium composition and by insulin: characterization of permissive and inductible C2 myoblasts. Differentiation 38:28-34
17. Maruta H, Burgess AW 1994 Regulation of the Ras signalling network. Bioessays 16:489-496
18. Myers MG, Grammer TC, Wang LM, Sun XJ, Pierce JH, Blenis J, White MF 1994 Insulin receptor subtrate-1 mediates phosphatidylinositol 3′-kinase and P70S6 kinase signaling during insulin, insulin-like growth factor-1, and interleukin-4 stimulation. J Biol Chem 269:28783-28789
19. Gronborg M, Wulff BS, Rasmussen JS, Kjeldsen T, Gammeltoft S 1993 Structure-function relationship of the insulin-like growth factor-I receptor tyrosine kinase. J Biol Chem 268:23435-23440
20. Tollefsen SE, Lajara R, McCusker RH, Clemmons DR, Rotwein P 1989 Insulin-like growth factors (IGF) in muscle development. Expression of IGF-I, the IGF-I receptor, and an IGF binding protein during myoblast differentiation. J Biol Chem 264:13810-13817
21. Coolkan SA, Ewton DZ, McWade FJ, Florini JR 1997 The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J Biol Chem 272:6653-6662
22. Pinset C, Garcia A, Rousse S, Dubois C, Montarras D 1997 Wortmannin inhibits IGF-dependent differentiation in the mouse myogenic cell line C2. C R Acad Sci Paris, Life Sciences 320:367-374
23. Montarras D, Aurade F, Johnson T, Ilan J, Gros F, Pinset C 1996 Autonomous differentiation in the mouse myogenic cell line, C2, involves a mutual positive control between insulin-like growth factor II and MyoD, operating as early as at the myoblast stage. J Cell Sci 109:551-560
24. Vlahos CJ, Matter WF, Hui KY, Brown RF 1994 A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269:5241-5248
25. Froeschlé A, Carnac G, Alric S, Montarras D, Pinset C, Rochette-Egly C, Bonnieu A 1996 RXRa is essential for mediating the all-trans retinoic acid-induced growth arrest of C2 myogenic cells. Oncogene 12:411-421
26. Schuller AG, Groffen C, van Neck JW, Zwarthoff EC, Drop SL 1994 cDNA cloning and mRNA expression of six mouse insulin-like growth factor binding proteins. Mol Cell Endocrinol 104:57-66
27. Hossenlopp P, Binoux M 1994 Use of peptide ligands for the detection of binding proteins. In: Protein blotting, a practical approach. Oxford University Press, pp 169-186
28. Lenormand P, McMahon M, Pouysségur J 1996 Oncogenic Raf-1 activates p70 S6 kinase via a mitogen-acrivated protein kinase-independent pathway. J Biol Chem 271:15762-15768
29. Wright WE, Sassoon DA, Lin VK 1989 Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell 56:607-617
30. Ballard FJ, Francis GL, Ross M, Bagley CJ, May B, Wallace JC 1987 Natural and synthetic forms of insulin-like growth factor-1 (IGF-1) and the potent derivative, destripeptide IGF-1: biological activities and receptor binding. Biochem Biophys Res Commun 149:398-404
31. Nakanishi S, Kakita S, Takahashi I, Kawahara K, Tsukuda E, Sano T, Yamada K, Yoshida M, Kase H, Matsuda Y, Hashimoto Y, Nonomura Y 1992 Wortmannin, a microbial product inhibitor of myosin light chain kinase. J Biol Chem 267:2157-2163
32. Abraham RT, Wiederrecht GJ 1996 Immunopharmacology of rapamycin. Annu Rev Immunol 14:483-510
33. Chung J, Kuo C, Crabtree G, Blenis J 1992 Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70kD S6 protein kinases. Cell 69:1227-1236
34. Price D, Grove J, Calvo V, Avruch J, Bierer B 1992 Rapamycin-induced inhibition of 70-kilodalton S6 protein kinase. Science 257:973-977
35. Hembree JR, Pampusch MS, Yang F, Causey JL, Hathaway MR, Dayton WR 1996 Cultured porcine myogenic cells produce insulin-like growth factor binding protein-3 (IGFBP-3) and transforming growth factor beta-1 stimulates IGFBP-3. J Anim Sci 74:1530-1540
36. Cohen P, Lamson G, Okajima T, Rosenfeld RG 1993 Transfection of the human insulin-like growth factor binding protein-3 gene into balb/c fibroblasts inhibits cellular growth. Mol Endocrinol 7:380-386
37. Valentinis B, Bhala A, DeAngelis T, Baserga R, Cohen P 1995 The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol Endocrinol 9:361-367
38. Lalou C, Lassare C, Binoux M 1996 A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-1 and insulin. Endocrinology 137:3206-3212
39. Mohseni Zadeh S, Binoux M 1997 The 16-kDa proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 inhibits the mitogenic action of fibroblast growth factor on mouse fibroblasts with a targeted disruption of the type 1 IGF receptor gene. Growth Regul 138:3069-3072
40. Rotwein P, James PL, Kou K 1995 Rapid activation of insulin-like growth factor binding protein-5 gene transcription during myoblast differentiation. Mol Endocrinol 9:913-923
41. Kay JE 1996 Stucture-function relationships in the FK506-binding protein (FKBP) family of peptidylprolyl cis-trans isomerases. Biochem 314:361-385
42. Chou MM, Blenis J 1995 The 70 kDa S6 kinase: regulation of a kinase with multiple roles in mitogenic signalling. Current Opin Cell Biol 7:806-814
43. Chung J, Grammer TC, Lemon KP, Kazlauska A, Blenis J 1994 PDGF- and insulin-dependent pp70S6 kinase activation mediated by phosphatidylinositol-3-OH kinase. Nature 370:71-75
44. Weng Q-P, Andrabi K, Klippel A, Kozlowski MT, Williams LT, Avruch J 1995 Phosphatidylinositol 3-kinase signals activation of p70 S6 kinase in situ through site-specific p70 phosphorylation. Proc Natl Acad Sci USA 92:5744-5748
45. i-coupled receptors. J Biol Chem 271:8537-8540
46. Brunn GJ, Williams J, Sabers C, Wiederrecht G, Lawrence JC, Abraham RT 1996 Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J 15:5256-5267
47. S6K. Proc Natl Acad Sci USA 92:11696-11700
48. RSK. Cell 86:465-474
49. Jefferies H, Reinhard C, Kozma S, Thomas G 1994 Rapamycin selectively represses translation of "polypyrimidine tract" mRNA family. Proc Natl Acad Sci USA 4441-4445
50. Terada N, Patel H, Takase K, Kohno K, Nairn A, Gelfand E 1994 Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins. Proc Natl Acad Sci USA 11:477-481
51. Conover CA, Clarkson JT, Bale LK 1995 Effect of glucocorticoid on insulin-like growth factor (IGF) regulation of IGF-binding protein expression in fibroblasts. Endocrinology 136:1403-1410
52. Dong Y, Canalis E 1995 Insulin-like growth factor (IGF) I and retinoic acid induce the synthesis of IGF-binding protein 5 in rat osteoblastic cells. Endocrinology 136:2000-2006
53. Duan C, Hawes SB, Prevette T, Clemmons DR 1996 Insulin-like growth factor-I (IGF-I) regulates IGF-binding protein-5 synthesis through transcriptional activation of the gene in aortic smooth muscle cells. J Biol Chem 271:4280-4288
54. James PL, Stewart CEH, Rotwein P 1996 Insulin-like growth factor binding protein-5 modulates muscle differentiation through an insulin-like growth factor-dependent mechanism. J Cell Biol 133:683-693
55. Parker A, Badley Clarke J, Busby WH, Clemmons DR 1996 Identification of the extracellular matrix binding sites for insulin-like growth factor-binding protein 5. J Biol Chem 271:13523-13529
56. Stewart CEH, Rotwein P 1996 Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts. J Biol Chem 271:11330-11338
57. Baserga R, Hongo A, Rubini M, Prisco M, Valentinis B 1997 The IGF-I receptor in cell growth, transformation and apoptosis. Biochim Biophys Acta 1332:F105-F126